Karas Eric

CIK 00019512871 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001951287

Recent Transactions

26 trades

Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2026-01-02+240,000→ 240,000 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-07-01−15,000→ 544,588 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-07-01$1.50/sh+15,000→ 25,315 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-07-01$16.99/sh−15,000→ 10,315 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-06-18−15,000→ 559,588 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-06-18$1.50/sh+15,000→ 22,696 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-06-18$16.00/sh−15,000→ 7,696 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-03-20−10,000→ 574,588 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-20$1.50/sh+10,000→ 17,696 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-03-20$14.00/sh−10,000→ 7,696 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2025-01-02+152,300→ 152,300 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$1.50/sh+6,283→ 11,976 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$14.00/sh−6,283→ 5,693 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-04−6,283→ 584,588 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$14.11/sh−3,717→ 5,693 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$1.50/sh+3,717→ 9,410 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-02−3,717→ 590,871 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-18$1.50/sh+10,000→ 15,693 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-09-18−10,000→ 594,588 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-18$14.00/sh−10,000→ 5,693 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-08-19−10,000→ 604,588 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-19$14.00/sh−10,000→ 5,693 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-19$1.50/sh+10,000→ 15,693 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2024-01-02+200,000→ 200,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2023-01-03+50,000→ 50,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2022-11-08+614,588→ 614,588 total

Companies

ARS Pharmaceuticals, Inc.
Chief Commercial Officer
$SPRY

Recent Filings

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov